Participant Motivation for Enrolling and Continuing in the FEM-PrEP HIV Prevention Clinical Trial Christina Wong, Caleb Parker, Khatija Ahmed, Kawango.
Leadership. Knowledge. Community. Antiplatelet Therapy for the Secondary Prevention of Cerebrovascular Disease Working Group: Ashfaq Shuaib, MD, FRCP;
Retention. Numbers that Matter 3476= total number of women enrolled at least 95% retention at each visit, at each study site 100% attention to data quality,
VAGINAL RING INSERTION INSTRUCTIONS
Nejmoa1007174 Appendix
